Shaanxi Meibang Pharmaceutical Group Co Ltd (605033) — Capital Reinvestment Ratio
Shaanxi Meibang Pharmaceutical Group Co Ltd (605033) has a Capital Reinvestment Ratio of 0.19x as of September 2025, meaning it reinvests 0% of its operating cash flow (CN¥281.88 Million) in capital expenditures (CN¥54.40 Million). See how much free cash does Shaanxi Meibang Pharmaceutical Group Co generate to measure how efficiently the company converts operating cash flow to free cash.
Capital Reinvestment Ratio
Operating Cash Flow
Capital Expenditures
Data as of
Shaanxi Meibang Pharmaceutical Group Co Ltd Capital Reinvestment Ratio (2017–2024)
This chart tracks Shaanxi Meibang Pharmaceutical Group Co Ltd's Capital Reinvestment Ratio across 7 annual periods.
Annual Capital Reinvestment Ratio for Shaanxi Meibang Pharmaceutical Group Co Ltd (2017–2024)
Year-by-year Capital Reinvestment Ratio for Shaanxi Meibang Pharmaceutical Group Co Ltd from 2017 to 2024. For live market cap and broader valuation context, see 605033 market cap overview.
| Year | Reinvestment Ratio | Operating CF (CNY) | Capital Expenditures | YoY Change |
|---|---|---|---|---|
| 2024 | 0.57x | CN¥280.40 Million | CN¥158.81 Million | ▼ -6.9% |
| 2023 | 0.61x | CN¥334.79 Million | CN¥203.69 Million | ▼ -29.6% |
| 2022 | 0.86x | CN¥126.41 Million | CN¥109.29 Million | ▲ +4.9% |
| 2020 | 0.82x | CN¥74.88 Million | CN¥61.71 Million | ▲ +213.4% |
| 2019 | 0.26x | CN¥128.45 Million | CN¥33.78 Million | ▼ -87.2% |
| 2018 | 2.06x | CN¥16.96 Million | CN¥34.86 Million | ▲ +244.2% |
| 2017 | 0.60x | CN¥29.41 Million | CN¥17.56 Million | — |